{"url":"https://lda.senate.gov/api/v1/filings/a855eb6e-d8d5-41f4-8d67-db313e61a4f2/","filing_uuid":"a855eb6e-d8d5-41f4-8d67-db313e61a4f2","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2022,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/a855eb6e-d8d5-41f4-8d67-db313e61a4f2/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Robert L. Livingston","dt_posted":"2022-04-20T12:03:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"499 S. CAPITOL STREET, S.W.","registrant_address_2":"SUITE 600","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":49635,"url":"https://lda.senate.gov/api/v1/registrants/49635/","house_registrant_id":34606,"name":"THE LIVINGSTON GROUP, LLC","description":"Government and Public Relations consultants","address_1":"425 3RD ST SW","address_2":"SUITE 1250","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT L. LIVINGSTON","contact_telephone":"+1 202-289-9881","dt_updated":"2026-07-10T14:52:56.951258-04:00"},"client":{"id":209638,"url":"https://lda.senate.gov/api/v1/clients/209638/","client_id":1005597,"name":"INNOVATIVE VACCINE TECHNOLOGIES","general_description":"Bio tech company","client_government_entity":false,"client_self_select":null,"state":"UT","state_display":"Utah","country":"US","country_display":"United States of America","ppb_state":"UT","ppb_state_display":"Utah","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-04-05"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"H.R. 2471 - Consolidated Appropriations Act, 2022 FY 2022 appropriations for the development of a synthetic vaccine","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":40853,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":"L","last_name":"LIVINGSTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42697,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"ALLEN","last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14319,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"CAMBON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63788,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"GLACKIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}